Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

被引:0
|
作者
Katerina Chatzidionysiou
Elisabeth Lie
Evgeny Nasonov
Galina Lukina
Merete Lund Hetland
Ulrik Tarp
Ioan Ancuta
Karel Pavelka
Dan C. Nordström
Cem Gabay
Helene Canhão
Matija Tomsic
Piet L. C. M. van Riel
Juan Gomez-Reino
Tore K. Kvien
Ronald F. van Vollenhoven
机构
[1] Karolinska Universitetssjukhustet,Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00
[2] Diakonhjemmet Hospital,Department of Rheumatology
[3] ARBITER,DANBIO, Department of Rheumatology
[4] Institute of Rheumatology,Department of Rheumatology
[5] Copenhagen University Hospital at Glostrup,undefined
[6] Aarhus University Hospital,undefined
[7] Cantacuzino Hospital,undefined
[8] Charles University,undefined
[9] ROB-FIN Helsinki University Central Hospital,undefined
[10] SCQM registry,undefined
[11] University Hospital of Geneva,undefined
[12] Rheumatic Diseases Portuguese Register,undefined
[13] Rheumatology Research Unit,undefined
[14] Instituto de Medicina Molecular,undefined
[15] University Medical Center,undefined
[16] Radboud University Nijmegen Medical Centre,undefined
[17] Hospital Clinico Universitet De Santiago,undefined
关键词
Rituximab; Rheumatoid arthritis; Observational;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] LONG-TERM EFFECTIVENESS OF ULTRA-LOW DOSES OF RITUXIMAB IN RHEUMATOID ARTHRITIS
    Den Broeder, N.
    Verhoef, L. M.
    De Man, Y. A.
    Kok, M. R.
    Thurlings, R. M.
    Van der Weele, W.
    Van den Bemt, B.
    Van den Hoogen, F.
    Van der Maas, A.
    Den Broeder, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 597 - 598
  • [22] GREATER EFFECTIVENESS OF SMALL DOSES OF CHLOROQUINE IN TREATMENT OF RHEUMATOID ARTHRITIS
    ISHMAEL, WK
    PAYNE, RW
    ARTHRITIS AND RHEUMATISM, 1961, 4 (01): : 114 - &
  • [23] Modelling of the cost-effectiveness of rituximab for treatment of rheumatoid arthritis in Italy
    De, VS
    Giuliani, G
    Diamantopoulos, A
    Brown, B
    Kielhorn, A
    VALUE IN HEALTH, 2006, 9 (03) : A26 - A26
  • [24] Characterization of Long-Term Responders to First Treatment Course of Rituximab (RTX)-Results From the CERERRA Collaboration
    Lie, Elisabeth
    Chatzidionysiou, Katerina
    Nasonov, Evgeny L.
    Lukina, Galina
    Pavelka, Karel
    Nordstrom, Dan C.
    Tomsic, Matija
    Gabay, Cem
    Ancuta, Ioan
    van Riel, Piet L. C.
    Gomez-Reino, Juan J.
    Fonseca, Joao E.
    Hetland, Merete L.
    Tarp, Ulrik
    Kvien, Tore K.
    van Vollenhoven, Ronald F.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S877 - S877
  • [25] COMPARATIVE STUDY OF RADIOLOGICAL AND THERAPEUTIC EFFECTS OF DIFFERENT DOSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kudryavceva, A.
    Lukina, G.
    Smirnov, A.
    Glukhova, S.
    Aronova, E.
    Gridneva, G.
    Kovalenko, P.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S360 - S360
  • [26] Rheumatoid arthritis and ocular myasthenia gravis: Effectiveness of rituximab in the management of these two diseases
    Novella-Navarro, Marta
    Salvatierra-Ossorio, Juan
    del Mar Munoz-Gomez, Maria
    Pavo-Blanco, Maria
    REUMATOLOGIA CLINICA, 2018, 14 (03): : 179 - 180
  • [27] High variability in glucocorticoid starting doses in patients with rheumatoid arthritis: observational data from an early arthritis cohort
    Albrecht, Katinka
    Callhoff, Johanna
    Schneider, Matthias
    Zink, Angela
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (08) : 1377 - 1384
  • [28] High variability in glucocorticoid starting doses in patients with rheumatoid arthritis: observational data from an early arthritis cohort
    Katinka Albrecht
    Johanna Callhoff
    Matthias Schneider
    Angela Zink
    Rheumatology International, 2015, 35 : 1377 - 1384
  • [29] Cost-effectiveness of rituximab as a new treatment modality for rheumatoid arthritis in Germany
    Rubbert, A
    Kielhorn, A
    Schach, S
    Brown, B
    Aristides, M
    VALUE IN HEALTH, 2006, 9 (03) : A25 - A25
  • [30] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Maurizio Benucci
    Gianantonio Saviola
    Paola Baiardi
    Mariangela Manfredi
    Rheumatology International, 2011, 31 : 1465 - 1469